Family Policy Alliance Condemns FDA Approval of New Generic Abortion Drug

For Immediate Release  Family Policy Alliance Condemns FDA Approval of New Generic Abortion Drug, Urges Trump Administration to Reverse Decision The U.S. Food and Drug Administration approved a new generic version of the abortion drug mifepristone earlier this week, despite strong evidence of its risks to women and clear opposition from states that have passed pro-life protections.Family Policy Alliance CEO Craig DeRoche issued the following statement:“This decision by the FDA is